Pfizer temporarily reduces European deliveries of vaccine

COPENHAGEN, Denmark — U.S. pharmaceutical company Pfizer confirmed Friday it will temporarily reduce deliveries to Europe of its COVID-19 vaccine while it upgrades production capacity to 2 billion doses per year.

The EU Commission chief said she'd immediately called Pfizer's CEO. But in an indication the issue might go beyond Europe, Canada's government said it was also affected.

Line Fedders, a spokeswoman for Pfizer Denmark, said that to meet the new 2 billion dose target Pfizer is upscaling production at its plant in Puurs, Belgium, which “presupposes adaptation of facilities and processes at the factory which requires new quality tests and approvals from the authorities.”

“As a consequence, fewer doses will be available for European countries at the end of January and the beginning of February,” she said.

“This temporary reduction will affect all European countries,” she said in a statement to The Associated Press.

Germany’s Health Ministry said Friday Pfizer had informed the European Commission, which was responsible for ordering vaccines from the company, that it won’t be able to fulfill all of the promised deliveries in the coming three to four weeks.

The ministry said German officials took note of the unexpected announcement by the Commission "with regret” because the company had made binding delivery commitments by mid-February.

“The federal and state governments expect the EU Commission to provide clarity and certainty as soon as possible in negotiations with Pfizer about further deliveries and delivery dates,” the statement said.

The Commission sealed the vaccine deals on behalf of all 27 member states, but is not responsible for the timetable and deliveries.

European Commission President Ursula von der Leyen said she had “immediately called the CEO of Pfizer.”

“He reassured me that all guaranteed doses of the first quarter will be delivered in the first quarter. He is personally on the case on reducing the delay period and to make sure that they will catch up as soon as possible,” von der Leyen said.

Earlier Friday Commission health policy spokesman Stefan de Keersmaecker said deliveries are made on the basis of purchase orders and specific contracts that are concluded between the member states and the companies.

"The specificities of these arrangements are laid down in these purchase orders or contracts,” he said.

The Commission has secured up to 600 million extra doses of the Pfizer vaccine that's produced in partnership with Germany's BioNTech.

Pfizer’s Belgian plant supplies all shots delivered outside the United States, including Canada where procurement minister Anita Anand said Friday that the U.S. drug-maker is temporarily reducing deliveries because of issues with its European production lines. While the company said it still was able to deliver four million doses by the end of March, that is no longer guaranteed, she said.